apollo
0
Written By ,
Reviewed By Hari Kumar , MBBS

About Darbitop 60Mcg/0.3Ml Inj

Darbitop 60Mcg/0.3Ml Inj belongs to the class of medication called 'blood-forming agent'  primarily used to treat anaemia (low red blood cell count) in person with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer (except for bone marrow or blood cells' cancer). Darbitop 60Mcg/0.3Ml Inj helps to reverse anaemia and reduce the need for blood transfusion. Anaemia occurs when the body has a lower amount of red blood cells or haemoglobin. In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia.

Darbitop 60Mcg/0.3Ml Inj contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. Darbitop 60Mcg/0.3Ml Inj is a biologic response modifier and erythropoiesis-stimulating protein. In chronic kidney disease, when the kidney fails to produce sufficient 'erythropoietin protein' which aids in the formation of red blood cells, Darbitop 60Mcg/0.3Ml Inj stimulates the production of this protein in the bone marrow. 

Darbitop 60Mcg/0.3Ml Inj will be injected by the healthcare provider. Do not self-administer. The most common side effects of Darbitop 60Mcg/0.3Ml Inj are shortness of breath,  cough, low blood pressure during dialysis, headache, body aches, diarrhoea, injection site pain and abdominal pain. Most of these sides effects of Darbitop 60Mcg/0.3Ml Inj do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

If you have uncontrolled/untreated high blood pressure or red cell aplasia (a type of anaemia) due to darbepoetin alfa or epoetin alfa, please inform your doctor before taking Darbitop 60Mcg/0.3Ml Inj to avoid any complications. Also, mention all the other medications you are taking to affect the way Darbitop 60Mcg/0.3Ml Inj works. Inform your doctor immediately, if you feel weak, lightheaded, tired, or short of breath, or if your skin looks pale as it may be signs that the body has stopped responding to Darbitop 60Mcg/0.3Ml Inj. 

rxMedicinePrescription drug

Whats That

tooltip
Non returnable*
COD available

Online payment accepted

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Apr-24

for this medicine

Uses of Darbitop 60Mcg/0.3Ml Inj

Anaemia (in cancer and chronic kidney disease) 

Medicinal Benefits

Darbitop 60Mcg/0.3Ml Inj is a human-made form of naturally occurring erythropoiesis-stimulating protein or erythropoietin (a hormone produced by the kidney's specialized cells and is responsible for protecting red blood cells against destruction and also stimulates the cells of bone marrow to produce more amount of red blood cells). Deficiency of erythropoietin happens when a person is suffering from chronic kidney diseases, which in turn cause low red blood cells count causing anaemia.  This medicine is primarily indicated for treating anaemia (low red blood cell count) in persons with long-term serious (chronic) kidney disease and persons receiving chemotherapy for some types of cancer except for bone marrow or blood cells' cancer. Darbitop 60Mcg/0.3Ml Inj contains a protein 'Darbepoetin alfa' which works by providing signals to the bone marrow to make more red blood cells. 

Side Effects of Darbitop 60Mcg/0.3Ml Inj

  • Shortness of breath
  • Cough
  • Hypotension (low blood pressure)
  • Headache
  • Body aches
  • Diarrhoea
  • Injection site pain 
  • Abdominal pain (stomach pain) 

 

Directions for Use

Darbitop 60Mcg/0.3Ml Inj will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Darbitop 60Mcg/0.3Ml Inj can enhance the risk of serious heart problems including heart attack so tell your doctor immediately if you notice shortness of breath, sudden numbness or weakness, chest pain, or trouble speaking or understanding. This medicine may also shorten survival time in some people with certain types of cancer. Inform your doctor before taking Darbitop 60Mcg/0.3Ml Inj if you have heart disease, high blood pressure, kidney disease, stroke, heart attack, blood clot, seizure, or latex allergy. Do not take Darbitop 60Mcg/0.3Ml Inj if you are pregnant or breastfeeding unless prescribed by the doctor. Darbitop 60Mcg/0.3Ml Inj may affect a person's ability to drive as it may cause convulsion during initial days of treatment, so a person taking Darbitop 60Mcg/0.3Ml Inj should avoid driving or operating any machine. Darbitop 60Mcg/0.3Ml Inj should not be given to children below 12 years of age, as safety and effectiveness have not been established. Avoid consuming alcohol along with Darbitop 60Mcg/0.3Ml Inj as it could lead to increased dizziness and sleepiness. 

Therapeutic Class

ERYTHROPOIESIS STIMULATING AGENTS (ESAs)

Drug-Drug Interactions

verifiedApollotooltip
Darbepoetin alfaThalidomide
Severe
Darbepoetin alfaLenalidomide
Severe

Drug-Drug Interactions

Login/Sign Up

Darbepoetin alfaThalidomide
Severe
How does the drug interact with Darbitop 60Mcg/0.3Ml Inj:
Taking thalidomide together with Darbitop 60Mcg/0.3Ml Inj may increase the risk of blood clots.

How to manage the interaction:
Although there is a possible interaction between Thalidomide and Darbitop 60Mcg/0.3Ml Inj, but it can be taken if your doctor has advised it. However, if you experience chest pain shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness, or swelling in an arm or leg; and numbness or weakness on one side of the body, contact a doctor immediately. Do not stop using any medications without consulting a doctor.
Darbepoetin alfaLenalidomide
Severe
How does the drug interact with Darbitop 60Mcg/0.3Ml Inj:
Taking Darbitop 60Mcg/0.3Ml Inj with Lenalidomide can increase the risk of blood clots.

How to manage the interaction:
Although there is an interaction between lenalidomide and Darbitop 60Mcg/0.3Ml Inj, it can be taken if your doctor has advised it. However, if you experience chest pain, shortness of breath, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness or swelling in an arm or leg, and numbness or weakness on one side of the body, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Darbepoetin alfaCarfilzomib
Severe
How does the drug interact with Darbitop 60Mcg/0.3Ml Inj:
Combining Darbitop 60Mcg/0.3Ml Inj with Carfilzomib can increase the risk of blood clots.

How to manage the interaction:
Although there is a possible interaction between Carfilzomib and Darbitop 60Mcg/0.3Ml Inj, you can take these medicines together if prescribed by your doctor. However, if you experience chest pain; shortness of breath; difficulty breathing; coughing up blood; sudden loss of vision; pain, redness, or swelling in an arm or leg; and numbness or weakness on one side of the body, contact a doctor immediately. Do not stop using any medications without consulting a doctor.
Darbepoetin alfaPomalidomide
Severe
How does the drug interact with Darbitop 60Mcg/0.3Ml Inj:
Taking Darbitop 60Mcg/0.3Ml Inj with Pomalidomide can increase the risk of dangerous blood clots.

How to manage the interaction:
Although there is a possible interaction between Pomalidomide and Darbitop 60Mcg/0.3Ml Inj, you can take these medicines together if prescribed by a doctor. However, If you experience chest pain, difficulty breathing, coughing up blood, sudden loss of vision, pain, redness, or swelling in an arm or leg, or numbness or weakness on one side of the body, consult a doctor immediately. Do not discontinue any medications without a doctor's advice.

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Food Interactions

Login/Sign Up

Drug-Diseases Interactions

verifiedApollotooltip
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Diseases Interactions

Login/Sign Up

Drug-Drug Interactions Checker List

  • THALIDOMIDE
  • CYCLOSPORINE
  • CAPTOPRIL

Diet & Lifestyle Advise

  • Limit the consumption of fluids, salt, potassium, phosphorous, and other electrolytes.
  • Eat a low-protein diet, and get enough calories from the foods if you are losing weight.
  • Eat foods that are high in vitamin B12, iron, and folic acid can fulfil the deficiencies of happed in kidney disease.
  • Include a little number of healthy fats in your diet that give you enough energy to be active during the day; however, try to limit fats that make you fatty. Try to include olive oil, peanut oil, and corn oil into your diet.
  • Rest well, get plenty of sleep.
  • Avoid smoking and alcohol consumption.
  • Using essential oils for massages can help increase circulation.

Habit Forming

No

Special Advise

  • Certain diagnostic tests like Complete blood count (CBC) can help check the count of red blood cells.
  • Have regular haemoglobin tests to check whether there is an improvement in the level of red blood cells after taking Darbitop 60Mcg/0.3Ml Inj or not.

Disease/Condition Glossary

Anaemia: It occurs when the body has a lower amount of red blood cells or haemoglobin than normal haemoglobin (iron-rich the protein responsible for allowing red blood cells to carry more oxygen from the lungs to the rest of the body).  In chronic kidney disease, the kidney gets damaged and doesn't filter the blood, leading to anaemia. Symptoms of anaemia in chronic kidney disease include fatigue or tiredness, shortness of breath, ashen skin, weakness, body aches, chest pain, dizziness, fainting, fast or irregular heartbeat, headache, sleep problems, and trouble in concentrating. 

Darbitop 60Mcg/0.3Ml Inj Substitute

Substitutes safety advice
  • Darbelife 200 Injection 0.4 ml

    8569.00per tablet
  • Actorise 200 mcg Injection 1's

    12305.70per tablet
  • Zynesp 200 mcg Injection 0.4 ml

    11427.50per tablet
whatsapp Floating Button

Add to Cart